SENZER Trademark

Trademark Overview


On Wednesday, September 2, 2015, a trademark application was filed for SENZER with the United States Patent and Trademark Office. The USPTO has given the SENZER trademark a serial number of 86745982. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 21, 2024. This trademark is owned by Kinhold IP Limited. The SENZER trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal, and cardiovascular disorders; substances adapted for medical use, namely, cannabinoids for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, other intestinal, neurological and cardiovascular disorders; vaccines for the treatment of pain, asthma, chronic obstructive pulmona...

Inhalers for medical purposes; filters for inhalers for medical purposes; inhalers for medical use; inhalers for therapeutic use; drug delivery systems; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; microneedle arrays for delivering medications; hypodermic syringes for injections for medical purposes; all of the aforesaid for use in delivering pharmaceutical preparations for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, mental illness, and intestinal, neurological and cardiovascular disorders; none of the aforesaid being for or in relation to preparations for the treatment of liver diseases
senzer

General Information


Serial Number86745982
Word MarkSENZER
Filing DateWednesday, September 2, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 21, 2024
Registration Number5348473
Registration DateTuesday, December 5, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal, and cardiovascular disorders; substances adapted for medical use, namely, cannabinoids for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, other intestinal, neurological and cardiovascular disorders; vaccines for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and intestinal and cardiovascular disorders; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; drug delivery agents in the form of powders, capsules, inhalers, that facilitate the delivery of pharmaceutical preparations; none of the aforesaid being for or in relation to preparations for the treatment of liver diseases
Goods and ServicesInhalers for medical purposes; filters for inhalers for medical purposes; inhalers for medical use; inhalers for therapeutic use; drug delivery systems; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; microneedle arrays for delivering medications; hypodermic syringes for injections for medical purposes; all of the aforesaid for use in delivering pharmaceutical preparations for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, mental illness, and intestinal, neurological and cardiovascular disorders; none of the aforesaid being for or in relation to preparations for the treatment of liver diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 21, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 21, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSENZER LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressLONDON EC1V 1NY
GB

Party NameKinhold IP Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLondon EC1Y2AB
GB

Party NameKinhold IP Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon EC1Y2AB
GB

Party NameKinhold IP Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon EC1Y2AB
GB

Trademark Events


Event DateEvent Description
Tuesday, December 15, 2015ASSIGNED TO EXAMINER
Saturday, September 5, 2015NEW APPLICATION ENTERED
Tuesday, September 8, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 10, 2015TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, December 15, 2015ASSIGNED TO LIE
Tuesday, December 15, 2015PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, December 17, 2015ASSIGNED TO EXAMINER
Tuesday, December 22, 2015NON-FINAL ACTION WRITTEN
Tuesday, December 22, 2015NON-FINAL ACTION E-MAILED
Tuesday, December 22, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 22, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 23, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 23, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 13, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 18, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 21, 2016PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, July 21, 2016WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
Thursday, July 21, 2016SUSPENSION LETTER WRITTEN
Thursday, July 21, 2016LETTER OF SUSPENSION E-MAILED
Thursday, July 21, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, January 30, 2017SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, February 1, 2017SUSPENSION INQUIRY WRITTEN
Wednesday, February 1, 2017INQUIRY TO SUSPENSION E-MAILED
Wednesday, February 1, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, July 24, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, July 26, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 26, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 7, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 11, 2017ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, August 14, 2017ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, August 30, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 19, 2017PUBLISHED FOR OPPOSITION
Tuesday, September 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 5, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, August 26, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, December 5, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, September 14, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Thursday, September 14, 2023WITHDRAWAL OF ATTORNEY GRANTED
Friday, June 21, 2024CANCELLED SEC. 8 (6-YR)